Immuno-Biological Laboratories Co., Ltd.

4570・Growth Market・Pharmaceuticals

4570・Growth Market・Pharmaceuticals

Immuno-Biological Laboratories Co., Ltd.4570

Reference Indicators

Market Cap

91¥100M

P/E (Forecast)

26.3x

P/B

5.0x

Dividend Yield (Forecast)

0.76%

ROE

19.6%

EV/EBITDA

27.8x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	647	794	816	969	1,004
Cost of Sales	270	267	299	335	297
Gross Profit	376	526	517	634	707
SG&A Expenses	498	468	412	425	425
Operating Income	-122	58	104	209	281
Non-operating Income	32	19	22	4	20
Non-operating Expenses	153	227	1	4	1
Ordinary Income	-243	-149	125	209	300
Extraordinary Income	0	45	—	—	—
Extraordinary Losses	7	176	0	—	—
Pre-tax Income	-250	-280	124	209	300
Income Taxes	8	9	-62	-39	-28
Net Income	-258	-289	186	249	329
EBITDA	—	—	106	224	299
Gross Margin	58.2%	66.3%	63.3%	65.4%	70.4%
Operating Margin	-18.9%	7.3%	12.8%	21.6%	28.0%
ROA	-15.2%	-20.2%	11.5%	13.5%	15.3%
ROE	-18.9%	-26.9%	15.9%	17.9%	19.6%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
抗体関連事業	1,002	281	28.0%
化粧品関連事業	2	-0	0.0%

Disclaimer